Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns
Authors:
- Pia EgerupPEPia Egerup
- Line Fich OlsenLOLine Fich Olsen
- Ann-Marie Hellerung Msc ChristiansenACAnn-Marie Hellerung Msc Christiansen
- David WestergaardDWDavid Westergaard
- Elin Rosenbek Bsc(Med) SeverinsenESElin Rosenbek Bsc(Med) Severinsen
- Kathrine Vauvert Römmelmayer Bsc(Med) HviidKHKathrine Vauvert Römmelmayer Bsc(Med) Hviid
- Astrid Marie KolteAKAstrid Marie Kolte
- Amalie Dyhrberg Bsc(Med) BojeABAmalie Dyhrberg Bsc(Med) Boje
- Marie-Louise Mathilde Friis Bsc(Med) BertelsenMBMarie-Louise Mathilde Friis Bsc(Med) Bertelsen
- Lisbeth PrætoriusLPLisbeth Prætorius
- Anne Msc ZedelerAZAnne Msc Zedeler
- Josefine Reinhardt Bsc(Med) NielsenJNJosefine Reinhardt Bsc(Med) Nielsen
- 27 October 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 137 (1) , 49-55
Abstract
OBJECTIVE: To investigate the frequency of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in parturient women, their partners, and their newborns and the association of such antibodies with obstetric and neonatal outcomes. METHODS: From April 4 to July 3, 2020, in a single university hospital in Denmark, all parturient women and their partners were invited to participate in the study, along with their newborns. Participating women and partners had a pharyngeal swab and a blood sample taken at admission; immediately after delivery, a blood sample was drawn from the umbilical cord. The swabs were analyzed for SARS-CoV-2 RNA by polymerase chain reaction, and the blood samples were analyzed for SARS-CoV-2 antibodies. Full medical history and obstetric and neonatal information were available. RESULTS: A total of 1,313 parturient women (72.5.% of all women admitted for delivery at the hospital in the study period), 1,188 partners, and 1,206 newborns participated in the study. The adjusted serologic prevalence was 2.6% in women and 3.5% in partners. Seventeen newborns had SARS-CoV-2 immunoglobulin G (IgG) antibodies, and none had immunoglobulin M antibodies. No associations between SARS-CoV-2 antibodies and obstetric or neonatal complications were found (eg, preterm birth, preeclampsia, cesarean delivery, Apgar score, low birth weight, umbilical arterial pH, need for continuous positive airway pressure, or neonatal admission), but statistical power to detect such differences was low. Full serologic data from 1,051 families showed an absolute risk of maternal infection of 39% if the partner had antibodies. CONCLUSION: We found no association between SARS-CoV-2 infection and obstetric or neonatal complications. Sixty-seven percent of newborns delivered by mothers with antibodies had SARS-CoV-2 IgG antibodies. A limitation of our study is that we lacked statistical power to detect small but potentially meaningful differences between those with and without evidence of infection.Keywords
All Related Versions
This publication has 9 references indexed in Scilit:
- Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational studyThe Lancet Microbe, 2020
- Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal FactorsFrontiers in Immunology, 2020
- Pregnancy and postpartum outcomes in a universally tested population for SARS‐CoV‐2 in New York City: a prospective cohort studyBJOG: An International Journal of Obstetrics & Gynaecology, 2020
- SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaScience Immunology, 2020
- Association between ABO blood groups and risk of SARS‐CoV‐2 pneumoniaBritish Journal of Haematology, 2020
- Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experienceJournal of Medical Virology, 2020
- Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, ChinaBMJ Global Health, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG TransportNature, 1966